Anti-inflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway

Journal of Investigative Dermatology

Volumn 128, Issue 2, 2008, Pages 336-344

  Sur, Runa ^a   Babad, Jeffrey M ^a   Garay, Michelle ^a   Liebel, Frank T ^a   Southall, Michael D ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR; SERTACONAZOLE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IRRITANT DERMATITIS; KERATINOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 38149119628     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700972     Document Type: Article

References (52)

1. Agut J, Tarrida N, Sacristan A, Ortiz JA (1996) Antiinflammatory activity of topically applied sertaconazole nitrate. Methods Find Exp Clin Pharmacol 18:233-4
2. Askari N, Diskin R, Avitzour M, Capone R, Livnah O, Engelberg D (2007) Hyperactive variants of P38alpha induce, whereas hyperactive variants of P38gamma suppress AP-1-mediated transcription. J Biol Chem 282:91-9
3. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M (1996) Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 390:165-9
4. Betz M, Fox BS (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108-13
5. Blanc A, Pandey NR, Srivastava AK (2003) Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease (review). Int J Mol Med 11:229-34
6. Campbell WB, Halushka PV (1996) Eicosanoids and platelet-activating factor. In: Goodman and Gilman's pharmacological basis of therapeutics. (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds). New York, NY: McGraw-Hill, pp 601-616
7. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, Urabe K, Furue M (2002) Propionibacterium acnes-induced IL-8 production may be mediated by NF-kB activation in human monocytes. J Dermatol Sci 29:97-103
8. 2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci STKE 2005:pe47
9. Das S, Fraga CG, Das DK (2006) Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radical Res 40:1066-75
10. Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, Dashti S (2003) p38 mitogen-activated protein kinases on the body surface - a function for p38 delta. J Invest Dermatol 120:823-8
11. Efimova T, Broome AM, Eckert RL (2003) A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem 278:34277-85
12. Efimova T, Deucher A, Kuroki T, Ohba M, Eckert RL (2002) Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha. J Biol Chem 277:31753-60
13. Enslen H, Raingeaud J, Davis RJ (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 273:1741-8
14. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC et al. (1995) Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 305(Part 2):479-84
15. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P (1997) Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J 16:3563-71
16. Gonzalez GA, Montminy MR (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675-80
17. Grandjean-Laquerriere A, Naour RL, Gangloff SC, Guenounou M (2005) Contribution of protein kinase A and protein kinace C pathways in ultraviolet B-induced IL-8 expression by human keratinocytes. Cytokine 29:197-207
18. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Res 74:1141-8
19. Griendling KK, Ushio-Fukai M (2000) Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91:21-7
20. Hay CH, Trevethick MA, Wheeldon A, Bowers JS, de Belleroche JS (1997) The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 78:843-50
21. Hu MC, Wang YP, Mikhail A, Qiu WR, Tan TH (1999) Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J Biol Chem 274:7095-102
22. Kaminska B (2005) MAPK signalling pathways as molecular targets for antiinflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754:253-62
23. Kanda N, Mitsui H, Watanabe S (2004) Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 114:1403-9
24. Katayama H, Kawada A (1981) Exacerbation of psoriasis induced by indomethacin. J Dermatol 8:323-7
25. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A et al. (2002) Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46:3113-7
26. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR (1997) Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533-8
27. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20:4265-74
28. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612-9
29. Liebel F, Lyte P, Garay M, Babad J, Southall MD (2006) Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res 298:191-9
30. Lloret S, Moreno JJ (1995) Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. Biochem Pharmacol 50:347-53
31. Marcinkiewicz J, Chain BM (1993) Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP. Cell Immunol 149:303-14
32. Masquilier D, Sassone-Corsi P (1992) Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem 267:22460-6
33. McMillen MA, Kharma B, Fuortes M, Schaefer HC, McGowan EA, Baumgarten WK et al. (1991) Cyclosporine effect on anti-CD3 monoclonal antibody-stimulated mitogenesis, phorbol ester comitogenesis, and PGE2 production. J Surg Res 51:66-71
34. Mitra S, Abraham E (2006) Participation of superoxide in neutrophil activation and cytokine production. Biochim Biophys Acta 1762:732-41
35. Moncada S, Ferreira SH, Vane JR (1973) Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 246:217-9
36. Nigg EA, Hilz H, Eppenberger HM, Dutly F (1985) Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus. EMBO J 4:2801-6
37. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Rev 22:153-83
38. Rao TS, Currie JL, Shaffer AF, Isakson PC (1993) Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17:723-41
39. Raud J, Dahlen SE, Sydbom A, Lindbom L, Hedqvist P (1988) Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 85:2315-9
40. 2 gel improvement of psoriatic lesions. Int J Dermatol 25:266-8
41. Robertson RP (1998) Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 47: 1379-83
42. Saklatvala J (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4:372-7
43. Sawafuji K, Miyakawa Y, Kizaki M, Ikeda Y (2003) Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways. Am J Hematol 72:67-9
44. Schieven GL (2005) The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem 5:921-8
45. Serhan CN, Levy B (2003) Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc Natl Acad Sci USA 100:8609-11
46. 2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury. Surgery 130:249-55
47. Sully G, Dean JL, Wait R, Rawlinson L, Santalucia T, Saklatvala J et al. (2004) Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequenceelement-binding protein 1). Biochem J 377:629-39
48. Treede RD, Meyer RA, Raja SN, Campbell JN (1992) Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38:397-421
49. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biol 231:232-5
50. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J et al. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91:2046-50
51. Vassiliou E, Jing H, Ganea D (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cellular Immunol 223:120-32
52. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-8